FOUR-YEAR RESULTS OF A PHASE 2 STUDY OF THE CATESPIN K INHIBITOR ODANACATIB IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: EFFECTS ON BONE TURNOVER MARKERS

Author(s):
Papapoulos, S.; Portales, J.R.; Petrovic, R.; Rosenberg, E.; DaSilva, C.; Santora, A.; Lombardi, A.; Binkley, N.; Bone, H.; Eisman, J.; Hosking, D.; Langdahl, B.; McClung, M.; Reid, I.; Resch, H.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-03-31
Language
English
Is part of
hdl
1887/118217